Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

EGRXEGRX
25 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in EAGLE PHARMACEUTICALS INC

GEODE CAPITAL MANAGEMENT, LLC previously held 0 shares of EGRX (EAGLE PHARMACEUTICALS INC), worth $0 as of 2024-Q4.

Final Value

$0

Final Shares

0

Total Value Change

-$10.6M

Total Shares Change

-264,086

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q4
Latest
Exited
0
-100.0%
$00.0%$0.50
0
2024-Q3
Decreased
105,846
-2.0%
$394,9030.0%$3.95
0
2024-Q2
Decreased
108,004
-53.4%
$604,9760.0%$5.60
0
2024-Q1
Increased
231,641
+2.8%
$1.2M0.0%$5.24
26
2023-Q4
Increased
225,295
+2.5%
$1.2M0.0%$5.23
26
2023-Q3
Increased
219,844
+2.3%
$3.5M0.0%$15.77
27
2023-Q2
Increased
214,994
+5.8%
$4.2M0.0%$19.47
28
2023-Q1
Increased
203,153
+1.4%
$5.8M0.0%$27.88
27
2022-Q4
Increased
200,305
+1.9%
$5.9M0.0%$29.23
28
2022-Q3
Increased
196,597
+3.5%
$5.2M0.0%$28.60
28
2022-Q2
Decreased
189,848
-7.5%
$8.4M0.0%$43.12
0
2022-Q1
Increased
205,122
+0.3%
$10.2M0.0%$49.50
28
2021-Q4
Decreased
204,402
-3.9%
$10.4M0.0%$51.10
0
2021-Q3
Increased
212,649
+5.6%
$11.9M0.0%$55.09
29
2021-Q2
Increased
201,458
+8.2%
$8.6M0.0%$42.14
30
2021-Q1
Increased
186,147
+18.6%
$7.8M0.0%$41.06
32
2020-Q4
Decreased
156,949
-1.8%
$7.3M0.0%$46.50
0
2020-Q3
Decreased
159,881
-3.7%
$6.8M0.0%$41.88
0
2020-Q2
Increased
166,037
+7.5%
$8M0.0%$48.02
30
2020-Q1
Decreased
154,469
-52.1%
$7.1M0.0%$45.31
0
2019-Q4
Increased
322,234
+102.7%
$19.4M0.0%$59.89
46
2019-Q3
Increased
158,990
+1.4%
$9M0.0%$56.43
28
2019-Q2
Increased
156,788
+3.6%
$8.7M0.0%$55.68
29
2019-Q1
Decreased
151,309
-42.7%
$7.6M0.0%$50.49
0
2018-Q4
New
264,086
-
$10.6M0.0%$39.23
38

Other major holders of EGRX: BNP PARIBAS FINANCIAL MARKETS, Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used